SBMU, Pharmaceutical Research Sciences
  • Register
  • Login
International Pharmacy Acta
  • Home
  • Journal Info
    • About
    • Aim and Scope
    • Ownership & Management
    • Indexing
    • Editorial Team
  • New Submission
  • Author Guidelines
    • Guideline
    • Types of articles
    • Templates
    • Publication Fees
  • Policies and Process
    • Publication Policy
    • Peer Review Process
    • Open Access Policy
    • plagiarism
    • Archiving
    • Privacy Statement
    • Copyright Notice
    • Waiver policy
    • Complaints Policy
    • Post- Publication Discussions and Corrections Policy
    • Advertisement and Marketing
  • Issues
    • Current
    • Archives
  • Contact us
Advanced Search
  1. Home
  2. Archives
  3. Vol. 2 No. 1 (2019)
  4. Original Research article

Vol. 2 No. 1 (2019)

December 2019

Use of Green Fluorescent Protein (GFP) Vector in Classical Restriction Enzyme-based Cloning Methods of Gateway Cloning System

  • fatemeh naddafi
  • Maryam Tabarzad
  • Farshad H. Shirazi

International Pharmacy Acta, Vol. 2 No. 1 (2019), 16 December 2019 , Page 2e6:1-5
https://doi.org/10.22037/ipa.v2i1.22719 Published: 2019-08-05

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Generating of an expression clone that can produce the pharmaceutical proteins in an efficient and soluble form at high levels is considered as an important step in pharmaceutical industry. Recombination-based cloning could be a quick and efficient way for generating expression vectors. Thus, both efficient and robust subcloning is vital for the construction of gene expression vectors. In this study, we used the traditional restriction enzyme-based cloning methods for generation of expression-ready clones by the most well-known commercial cloning technologies, Gateway.

Keywords:
  • GFP
  • Gateway cloning technology
  • pEGFP-N1
  • pTracer-SV40
  • plasmid
  • PCR
  • PDF

How to Cite

naddafi, fatemeh, Tabarzad, M., & H. Shirazi, F. (2019). Use of Green Fluorescent Protein (GFP) Vector in Classical Restriction Enzyme-based Cloning Methods of Gateway Cloning System. International Pharmacy Acta, 2(1), 2e6:1–5. https://doi.org/10.22037/ipa.v2i1.22719
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

References

Reece-Hoyes JS, Walhout AJ. Gateway recombinational cloning. Cold Spring Harbor Protocols. 2018;2018(1):pdb. top094912.

Sasaki Y, Sone T, Yoshida S, Yahata K, Hotta J, Chesnut JD, et al. Evidence for high specificity and efficiency of multiple recombination signals in mixed DNA cloning by the Multisite Gateway system. Journal of biotechnology. 2004;107(3):233-43.

Petersen LK, Stowers RS. A Gateway MultiSite recombination cloning toolkit. PloS one. 2011;6(9):e24531.

Katzen F. Gateway® recombinational cloning: a biological operating system. Expert opinion on drug discovery. 2007;2(4):571-89.

Esposito D, Garvey LA, Chakiath CS. Gateway cloning for protein expression. High Throughput Protein Expression and Purification: Springer; 2009. p. 31-54.

Wang G-F, Qi B, Tu L-L, Liu L, Yu G-C, Zhong J-X. Construction of adenovirus vectors encoding the lumican gene by gateway recombinant cloning technology. International journal of ophthalmology. 2016;9(9):1271.

Zhao R, Rong Q, Liu Y, Shen Y, Huang L. Construction of RNAi vectors for SmNAC1 transcription factors of Salvia miltiorrhiza using Gateway cloning technology. Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China journal of Chinese materia medica. 2014;39(9):1569-73.

Hope IA, Stevens J, Garner A, Hayes J, Cheo DL, Brasch MA, et al. Feasibility of genome-scale construction of promoter:: reporter gene fusions for expression in Caenorhabditis elegans using a multisite gateway recombination system. Genome research. 2004;14(10b):2070-5.

Magnani E, Bartling L, Hake S. From Gateway to MultiSite Gateway in one recombination event. BMC molecular biology. 2006;7(1):46.

  • Abstract Viewed: 523 times
  • PDF Downloaded: 343 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors
  • For Librarians

Make a Submission

Make a Submission
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License.

 

                                                  Online ISSN: 2645-3266

                                                  Print ISSN: 2645-3258                                                 

Powered by OJSPlus